IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes

What happened: IQVIA (NYSE:IQV) launched IQVIA Life Science Models at TechIQ 2026, a suite of models to help life sciences companies predict clinical trial outcomes. Key numbers: Initial evaluation across 50 trials and 270 endpoints found 85% of predictions were on target or clinically close. IQVIA has approximately 94,000 employees in over 100 countries. Why it matters: IQVIA says the models let customers simulate studies and test assumptions before execution, aiming to optimize study design and identify risks earlier. Market: +0.3% by next close ($258.88 on Oct 8), +16.3% YTD

IQVIA (NYSE:IQV) launched IQVIA Life Science Models at TechIQ 2026, a suite of models to help life sciences companies predict clinical trial outcomes.

IQVIA says the models let customers simulate studies and test assumptions before execution, aiming to optimize study design and identify risks earlier. Market: +0.3% by next close ($258.88 on Oct 8), +16.3% YTD